Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Discordance between Physiology and Imaging Guided PCI in Intermediate Coronary Lesions: Who to trust?

As regards intermediate coronary lesion intervention, physiological assessment is essential for culprit lesion identification and clinical decision making. It has been shown, in a randomized study, that physiology-guided percutaneous coronary intervention (PCI), along with intravascular ultrasound (IVUS), is not inferior for the combined two-year outcome of all-cause death, acute myocardial infarction (AMI), and revascularization.

Currently, the combination of these strategies is considered best practice. However, their discrepancies and clinical implications remain unclear.

The aim of this post-hoc analysis of the FLAVOUR study (Fractional Flow Reserve and Intravascular Ultrasound for Clinical Outcomes in Patients with Intermediate Stenosis) was to evaluate the discrepancy and relevance of physiological assessment in IVUS-guided PCI.

The Primary Endpoint was major adverse cardiovascular events (MACE) incidence, defined as a composite of death, acute myocardial infarction (AMI), and revascularization, at one-year follow-up.

Read also: Edge-to-Edge Repair in Atrial Secondary Tricuspid Regurgitation.

The Secondary Endpoint included angina frequency and quality of life, a per the Seattle Angina Questionnaire. Patients were classified based on IVUS use for PCI guidance (performed vs. deferred PCI) and QFR value, as follows:

Deferred Group: Negative QFR + deferred PCI.

Performed Group: Negative QFR + performed PCI.

Reference Group: Positive QFR + performed PCI.

34.4% of the 784 analyzed patients belonged to the deferred group, 29.3% to the performed group, and 31.5% to the reference group. Mean age was approximately 65, and most participants were male. The most frequently treated coronary artery was the left anterior descending, followed by the right coronary.

Cumulative MACE incidence at two years was 4.5%, 3.9%, and 9.4% for the deferred, performed, and reference groups, respectively (P = 0.019). MACE risk resulted higher among reference group patients vs. the performed group (HR: 2.46; 95% CI: 1.13–5.35; P = 0.023) and the deferred group (HR: 2.17; 95% CI: 1.07–4.38; P = 0.031). 

Read also: Trends in the Treatment of Critical Lower Limb Ischemia.

In patients with negative QFR, there were no prognostic differences between the performed and deferred groups as regards MACE (HR: 0.88; 95% CI: 0.37–2.11; P = 0.779) or AMI (HR: 1.48; 95% CI: 0.49–4.45; P = 0.484), and neither were there differences in secondary end point.

Conclusión 

Angiography-based physiological assessment may provide additional prognostic information in patients undergoing IVUS-guided PCI. IVUS guided PCI may not be beneficial in patients with functionally non-significant lesions. This sub-analysis should serve as springboard to generate new hypotheses and continue to evaluate the combination of these two therapeutic tools.

Original Title: Clinical Relevance of Discordance Between Physiology-and Imaging Guided PCI Strategies in Intermediate Coronary Stenosis.

Reference: Jinlong Zhang,MD,PHD et al JACC Cardiovasc Interv 2024. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...